During the past decade, Chosun University Hospital conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 6 clinical trials were completed, i.e. on average, 19.4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 5 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chosun University Hospital" #1 sponsor was "Samsung Medical Center" with 5 trials, followed by "Chosun University Hospital" with 4 trials sponsored, "Daiichi Sankyo, Inc." with 3 trials sponsored, "Gilead Sciences" with 3 trials sponsored and "Asan Medical Center" with 3 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chosun University Hospital" #1 collaborator was "Chosun University Hospital" with 4 trials as a collaborator, "Chonnam National University Hospital" with 2 trials as a collaborator, "Daiichi Sankyo Korea Co., Ltd." with 2 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "Bayer AG (Sponsor)" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Chosun University Hospital" are "Ischemic Heart Disease" (4 trials), "Ischemic Stroke" (4 trials), "Atrial Fibrillation" (2 trials), "Colitis, Ulcerative" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Chosun University Hospital" in a lesser frequency.

Most popular intervention types in "Chosun University Hospital" are "Drug" (30 trials), "Device" (6 trials), "Procedure" (5 trials), "Diagnostic Test" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Desflurane" (2 trials), "Dexmedetomidine" (2 trials), "Golimumab" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Chosun University Hospital" are 42 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Chosun University Hospital". undefined are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Chosun University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Chosun University Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 6 trials that are defined as “Not Applicable".

Chosun University Hospital has several departments that took part in Clinical trials: "Department of Neurology, Chosun University Hospital" - 3 trials